论文部分内容阅读
目的:观察肝硬化疾病诊断中生化检验指标特点。方法:随机选择我院自2013年5月至2015年7月收治的37例确诊为肝硬化患者作为本次研究的观察组,选择同期入我院进行体检的37例健康人群作为本次研究的对照组,全部患者均检测相关生化指标。结果:观察组患者DBL、TBL、TBA、ALT、AST、ALP及γ-GT的水平明显高于对照组患者(P<0.05),但CHE、A/G水平明显低于对照组患者(P<0.05)。结论:生化指标在诊断肝硬化疾病方面具有积极的参考价值,可临床推广应用。
Objective: To observe the characteristics of biochemical tests in the diagnosis of cirrhosis. Methods: Thirty-seven patients with cirrhosis who were admitted to our hospital from May 2013 to July 2015 were randomly selected as the observation group and 37 healthy subjects who were admitted to our hospital during the same period were enrolled in this study Control group, all patients were detected biochemical indicators. Results: The levels of DBL, TBL, TBA, ALT, AST, ALP and γ-GT in the observation group were significantly higher than those in the control group, but the levels of CHE and A / G were significantly lower than those in the control group (P < 0.05). Conclusion: Biochemical indicators in the diagnosis of cirrhosis disease has a positive reference value, which can be clinically applied.